5-Aminolevulinic acid hydrochloride - CAS 5451-09-2
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
5-Aminolevulinic acid hydrochloride
Catalog Number:
B0084-325429
Synonyms:
5-Amino-4-oxopentanoic acid hydrochloride; Levulan; Aminolevulinic acid hydrochloride; Levulan Kerastick
CAS Number:
5451-09-2
Description:
5-Aminolevulinic acid HCl is an intermediate in heme biosynthesis in the body and the universal precursor of tetrapyrroles. 5-Aminolevulinic acid is used as a photochemotherapy for actinic keratosis.
Molecular Weight:
167.59
Molecular Formula:
C5H9NO3.HCl
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
C(CC(=O)O)C(=O)CN.Cl
InChI:
InChI=1S/C5H9NO3.ClH/c6-3-4(7)1-2-5(8)9;/h1-3,6H2,(H,8,9);1H
InChIKey:
ZLHFONARZHCSET-UHFFFAOYSA-N
Targets:
Others
Catalog Number Size Price Stock Quantity
B0084-325429 10 g $188 In stock
Bulk Inquiry
Chemical Structure
CAS 5451-09-2 5-Aminolevulinic acid hydrochloride

Related Products


CAS 1256094-72-0 AI-10-49

AI-10-49
(CAS: 1256094-72-0)

AI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBFβ-SMMHC and disrupts its binding to RUNX1 with a FRET IC50 of 0.26 uM.

CAS 81720-05-0 Rehmannioside A

Rehmannioside A
(CAS: 81720-05-0)

Rehmannioside A is an iridoid glucoside extracted from the roots of Rehmannia glutinosa.

UNIL-088
(CAS: 473545-11-8)

UNIL088 is a water-soluble prodrug of cyclosporine A (CsA), can be rapidly hydrolysed under physiological conditions, and can retain a long shelf-life in aqueou...

Bethanidine Sulfate
(CAS: 114-85-2)

This active molecular is a guanidinium antihypertensive agent through adrenergic neuron-blocking.

CAS 491-70-3 Luteolin

Luteolin
(CAS: 491-70-3)

Luteolin is a flavonoid found in Terminalia chebula, which is a non-selective phisphodiesterase PDE inhibitor.

CAS 22608-11-3 Demethoxycurcumin

Demethoxycurcumin
(CAS: 22608-11-3)

Natural demethoxy curcuminoid. Anticancer, antiproliferative and antioxidant activity. Inhibits various signaling pathways including Wnt/β-catenin, AMPK and MAP...

CAS 23496-41-5 Peimine

Peimine
(CAS: 23496-41-5)

Anti-inflammatory agent. MAPK inhibitor. Inhibits p38, ERK and JNK phosphorylation. Inhibits NFκB activation. Shows antitussive, expectorant and anti-inflammato...

CAS 162203-65-8 JTP-4819

JTP-4819
(CAS: 162203-65-8)

JTP-4819, a pyrrolidine derivative, has been found to be a PEP inhibitor that was once studied in cognition disorders and had been already been discontinued.

CAS 108341-18-0 Noradrenaline bitartrate monohydrate

Noradrenaline bitartrate monohydrate
(CAS: 108341-18-0)

Noradrenaline bitartrate monohydrate is a direct alpha-adrenergic receptors stimulator.Noradrenaline modulates the gain of evoked activity, especially in sensor...

CAS 77303-18-5 AR-L 100 BS

AR-L 100 BS
(CAS: 77303-18-5)

AR-L 100 BS is a bio-active chemical with cardiovascular effects originated by oehringer Ingelheim Pharma KG. But no development was reported for Ischaemic hear...

CAS 81907-62-2 Ganoderic acid A

Ganoderic acid A
(CAS: 81907-62-2)

Ganoderic acids are a class of related triterpenoids found in Ganoderma mushrooms. Now ganoderic acid A and ganoderic acid B are well characterized. Some ganode...

JNJ-42259152
(CAS: 1301167-87-2)

This molecular is a phosphodiesterase 10A PET tracer. Related studies show that PDE10A activity can be reliably quantified and simplified using a reference tiss...

CGP 76030
(CAS: 497152-38-2)

CGP76030 is a ual-specific Src and Abl kinase inhibitor, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases.

CAS 1464-42-2 Selenomethionine

Selenomethionine
(CAS: 1464-42-2)

Selenomethionine is an essential nutrient that may have a role in other biologically active compounds, especially vitamin E and the enzyme formic dehydrogenase.

BPH715
(CAS: 1059677-23-4)

BPH715 is a new generation of lipophilic bisphosphonates. It is potent in cell culture and effectively inhibited tumor cell growth and invasiveness. It is used ...

CAS 52286-58-5 Ginsenoside Rf

Ginsenoside Rf
(CAS: 52286-58-5)

Ginsenoside Rf, extracted from the traditional Chinese herb ginseng, an anti-arthritic agent, attenuating collagen-induced arthritis in mice.

CAS 549-18-8 Amitriptyline Hydrochloride

Amitriptyline Hydrochloride
(CAS: 549-18-8)

Amitriptyline inhibits serotonin receptor, norepinephrine receptor, 5-HT4, 5-HT2 and sigma 1 receptor with IC50 of 3.45 nM, 13.3 nM, 7.31 nM, 235 nM and 287 nM,...

CAS 4204-99-3 MK190

MK190
(CAS: 4204-99-3)

MK190 is a synthetic bio-active chemical.

CAS 26328-04-1 Cinepazide maleate

Cinepazide maleate
(CAS: 26328-04-1)

Cinepazide maleate is a maleate salt form of cinepazide which is a vasodilator.

CAS 100646-51-3 Quizalofop-p-ethyl

Quizalofop-p-ethyl
(CAS: 100646-51-3)

Quizalofop-P-ethyl, a quinoxaline derivative, is a sort of post-emergence herbicide that might be effective in regulating annual and perennial grass weeds.

Reference Reading


1.Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminate.
Zhang Z1, Lu XN1, Liang J1, Tang H1, Yang YS1, Zhu XH1, Du J1, Shen YY1, Xu JH1. Int J Clin Exp Med. 2015 Apr 15;8(4):6517-21. eCollection 2015.
OBJECTIVES: To investigate the efficacy and safety of topical application of 5-aminolaevulinic acid (ALA) photodynamic therapy (PDT) for the treatment of condylomata acuminata (CA) in larger population.
2.Fluorescent detection of peritoneal metastasis in human colorectal cancer using 5-aminolevulinic acid.
Kondo Y1, Murayama Y1, Konishi H1, Morimura R1, Komatsu S1, Shiozaki A1, Kuriu Y1, Ikoma H1, Kubota T1, Nakanishi M1, Ichikawa D1, Fujiwara H1, Okamoto K1, Sakakura C1, Takahashi K2, Inoue K2, Nakajima M2, Otsuji E1. Int J Oncol. 2014 Jul;45(1):41-6. doi: 10.3892/ijo.2014.2417. Epub 2014 May 6.
A precise diagnosis of peritoneal dissemination is necessary to determine the appropriate treatment strategy for colorectal cancer. However, small peritoneal dissemination is difficult to diagnose. 5-aminolevulinic acid (5-ALA) is an intermediate substrate of heme metabolism. The administration of 5-ALA to cancer patients results in tumor-specific accumulation of protoporphyrin IX (PpIX), which emits red fluorescence with blue light irradiation. We evaluated the usefulness of photodynamic diagnosis (PDD) using 5-ALA to detect the peritoneal dissemination of colorectal cancer. EGFP-tagged HT-29 cells were injected into the peritoneal cavity of BALB/c nude mice. After 2 weeks, the mice were given 5-ALA hydrochloride, and metastatic nodules in the omentum were observed with white light and fluorescence images. Twelve colorectal cancer patients suspected to have serosal invasion according to preoperative computed tomography (CT) were enrolled in this study.
3.Intraoperative Detection of Superficial Liver Tumors by Fluorescence Imaging Using Indocyanine Green and 5-aminolevulinic Acid.
Kaibori M1, Matsui K2, Ishizaki M2, Iida H2, Okumura T2, Sakaguchi T2, Inoue K2, Ikeura T3, Asano H4, Kon M2. Anticancer Res. 2016 Apr;36(4):1841-9.
BACKGROUND/AIM: Indocyanine green (ICG) and the porphyrin precursor 5-aminolevulinic acid (5-ALA) have been approved as fluorescence imaging agents in the clinical setting. This study evaluated the usefulness of fluorescence imaging with both ICG and 5-ALA for intraoperative identification of latent small liver tumors.
4.Type 2 diabetic conditions in Otsuka Long-Evans Tokushima Fatty rats are ameliorated by 5-aminolevulinic acid.
Sato T1, Yasuzawa T2, Uesaka A2, Izumi Y3, Kamiya A4, Tsuchiya K4, Kobayashi Y2, Kuwahata M2, Kido Y5. Nutr Res. 2014 Jun;34(6):544-51. doi: 10.1016/j.nutres.2014.04.013. Epub 2014 Apr 26.
A precursor of protoporphyrin IX, 5-aminolevulinic acid (5-ALA) is used as a prodrug for photodiagnosis and photodynamic therapy. Recently, it has been shown that 5-ALA reduces glucose levels during fasting and after glucose loading in prediabetic subjects. We hypothesized that 5-ALA ameliorates diabetic conditions through mitochondrial changes in visceral adipose tissue. In order to explore the metabolic effects on the type 2 diabetic state, we administered ALA hydrochloride in combination with sodium ferrous citrate to Otsuka Long-Evans Tokushima Fatty (OLETF) rats at intragastric doses of 20 and 300 mg kg(-1) d(-1) for 6 weeks. The administration of 300 mg kg(-1) d(-1) of 5-ALA improved glucose intolerance, hypertriglyceridemia, and hyperleptinemia in OLETF rats more effectively than the administration of an equivalent dose of metformin, in accordance with reductions in food intake and body weight. Furthermore, the weight of the retroperitoneal fat tended to decrease and cellular mitochondrial content of the fat was markedly reduced by the 5-ALA administration, showing a positive correlation.